Reviva Pharmaceuticals Holdings, Inc. Proceeds from Issuance of Private Placement
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Proceeds from Issuance of Private Placement of $0 for the 9-month period ending 2019-11-30, per its 10-Q filed 2020-01-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2020-05-04
- Reviva Pharmaceuticals Holdings, Inc. proceeds from issuance of private placement for the quarter ending 2019-11-30 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 5 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 8 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 11 month |
|---|---|---|---|---|---|---|
| 2019-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-01-10 | $0.00 10-Q · filed 2020-01-10 | ||||
| 2019-08-31 | $0.00 10-Q · filed 2019-10-08 | |||||
| 2019-02-28 | $3.59M 10-K · filed 2020-05-04 | |||||
| 2018-11-30 | $3.59M 10-Q · filed 2020-01-10 | |||||
| 2018-08-31 | $3.59M 10-Q · filed 2019-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |